A world leader in patient-centered care
Translating the next generation of cancer researchers
The most advanced treatment options available
View all adult cancer types
View all pediatric cancer types
Susan F. Smith Center for Women's Cancers
Gynecologic CancerBlood CancersCancer Genetics and PreventionCutaneous (Skin) CancerGastrointestinal CancerGenitourinary CancerHead and Neck CancerHematologyMelanomaNeuro-OncologySarcomaStem Cell TransplantThoracic (Lung) Cancer
Blood DisordersBrain TumorsHematologic MalignanciesSolid TumorsStem Cell Transplant
Backed by a growing body of research, investigators at Dana-Farber Cancer Institute are calling for all hospitals to establish bereavement programs for families of deceased patients.
Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.WebsiteVideoWhat do you #DiscoverCareBelieve?
Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.
New findings on prostate cancer from The Cancer Genome Atlas may enable doctors to make better diagnoses and prognoses for patients and provide novel directions for therapies.
The Commonwealth Foundation for Cancer Research has pledged $20 million to the Bridge Project, a collaborative research program of the Koch Institute for Integrative Cancer Research at MIT and Dana-Farber/Harvard Cancer Center, to accelerate the translation of interdisciplinary cancer solutions toward the clinic.
Turning off a single gene leads to a roughly three-to-five-fold gain in the yield of laboratory methods for producing red blood cells from stem cells, according to new research published in Cell Stem Cell. The findings suggest a way to cost-effectively manufacture red blood cells from stem cells; the patients who could potentially benefit include those who cannot use blood currently available in blood banks.
New research by Dana-Farber Cancer Institute scientists raises the prospect of cancer therapy that works by converting a tumor's best friends in the immune system into its gravest enemies.
A study led by Dr. David Reardon shows a new vaccine increases long term survival in certain brain cancer patients.
Dr. Anthony D’Amico comments on the availability of the PSA test for men to check for Prostate cancer.
Lisa Diller comments on a study that shows a substantial number of children with cancer carry cancer-predisposing mutations inherited from a parent.
Fewer U.S. men are being screened for prostate cancer, and fewer cases of the disease are being diagnosed nationwide, according to researchers at Dana-Farber.
Dr. Ann Partridge comments on breast cancer patients who are pregnant and how they should be vigilant about reporting any symptoms to their doctor.
Seven major U.S. and European cancer institutions including Dana-Farber are banding together to study the massive amounts of data produced by sequencing tests in an effort to improve treatment decisions.
A Dana-Farber patient talks about the Executive Council luncheon aimed at supporting the Susan F. Smith Center for Women’s Cancers at the Institute.
Dr. Mehra Golshan talks about the benefits of a new advance in reconstructive surgery for women with breast cancer.
10:00 AM - 11:30 AM
Smith Building, Room 330
In this class you will learn exercises of the mind/body through mindfulness awareness and fluid movement. These techniques will help you to relax, increase concentration, while utilizing the mind, body and spirit to help improve quality of life. This class is open to patients who have been newly diagnosed with cancer, are receiving treatment, or in remission. Family, friends and staff are welcome. Please call the Zakim Center to register at 617-632-3322 or email Zakim_Center@dfci.harvard.edu.
Tai Chi for Optimal Health with Ramel Rones
11:30 AM - 1:00 PM
An Internal Chinese martial art practiced for both defense training and
health benefits. Learn sitting and standing techniques as well as slow moving
meditation. Family, friends and staff are welcome.
For more information or to register, please contact the Zakim Center at
617-632-3322 or Zakim_Center@dfci.harvard.edu.
2:00 PM - 3:00 PM
Connect to your breath, body, and joy through group singing.
Discover how group singing can support relaxation, mood, sense of community,
and pain management. Lyrics will be provided. Song requests and discussion are
welcome, and no prior music experience is required. Family, friends and staff are welcome.
To register please call 617-692-3322 or email: Zakim_Center@dfci.harvard.edu.
Patient referral information, clinical resources and more.
For adults:877-442-3324Quick access: Appointments as soon as the next day for new adult patientsFor children:888-733-4662
Search current cancer clinical trials at Dana-Farber.
There are many ways to support Dana-Farber and the Jimmy Fund.
Top-ranked cancer center in New England for adults (with Brigham and Women's Hospital) — #1 in the nation for children (with Boston Children's Hospital)
Insight features the latest in cancer care and research news from Dana-Farber.Read the blog
Stay current on the latest news by signing up for Spotlight, our email newsletter.View current issueSubscribe now
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: